Clinical trial
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy
NCT01183767 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 30, 2010
- Completion date
- September 6, 2018
- Enrollment
- 33 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
duchenne muscular dystrophy